A Phase I Trial of Proleukin and Rapamune in Recent-onset Type 1 Diabetes Mellitus (ITN018AI)
Phase of Trial: Phase I
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Aldesleukin (Primary) ; Sirolimus (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 23 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Jun 2010 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.